Second oral antiviral for COVID-19 on PBS broadens options for GPs
This comes as experts rule out routine use of sotrovimab against circulating subvariants and a new hybrid variant, Deltacron, emerges in Australia
A second oral antiviral for treating patients with COVID-19 at high risk of disease progression will be PBS listed from 1 May, the Federal Government says.
GPs will be able to write a script for nirmatrelvir–ritonavir (Paxlovid), and patients can fill it at their local pharmacy, Minister for Health Greg Hunt says.
